Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that the Company will participate in the virtual H.C. Wainwright Global Life Sciences Conference. The fireside chat will be made available for on-demand listening beginning Tuesday, March 9, 2021 at 7:00 a.m. EST.

The webcast of the fireside chat will be available on the “Media” section of the Company’s website at www.verastem.com under “Events & Presentations”.

About Verastem Oncology

Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition. For more information, please visit www.verastem.com.

Verastem Oncology Contacts: Investors: Ajay Munshi Vice President, Corporate Development +1 781-469-1579 amunshi@verastem.com Sherri Spear Argot Partners +1 212 600 1902 sherri@argotpartners.com Media: Lisa Buffington Corporate Communications +1 781-292-4205 lbuffington@verastem.com

Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Verastem Charts.
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Verastem Charts.